Antibacterial activity of BMS-180680, a new catechol-containing monobactam

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1010-1016

  Fung Tomc, Joan ^a,b   Bush, Karen ^a,c   Minassian, Beatrice ^a   Kolek, Benjamin ^a   Flamm, Robert ^a,d   Gradelski, Elizabeth ^a   Bonner, Daniel ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Department of Microbiology/104 ^*  (United States)

^c ASTRAZENECA   (United Kingdom)

^d ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BMS 180680; CATECHOL DERIVATIVE; CEFALORIDINE; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; MONOBACTAM DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CITROBACTER; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS;

EID: 0030902573     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1010     Document Type: Article

References (26)

1. Arisawa, M., Y. Sekine, S. Shimuzu, H. Takano, P. Angehrn, and R. L. Then. 1991. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity. Antimicrob. Agents Chemother. 35:653-659.
2. Braun, V., R. E. W. Hancock, K. Hantke, and A. Hartmann. 1976. Functional organization of the outer membrane of Escherichia coli: phage and colicin receptors as components of iron uptake systems. J. Supramol. Struct. 5:37-58.
3. Bush, K., and S. B. Singer. 1989. Biochemical characteristics of extended broad spectrum β-lactamases. Infection 17:429-433.
4. Crichton, R. R., and M. Charloteaux-Wauters. 1987. Iron transport and storage Eur. J. Biochem. 164:485-506.
5. Curtis, N. A. C., R. L. Eisenstadt, S. J. East, R. J. Cornford, L. A. Walker, and A. J. White. 1988. Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins. Antimicrob. Agents Chemother. 32:1879-1886.
6. Hancock, R. E. W., K. Hantke, and V. Braun. 1977. Iron transport in Escherichia coli K-12: 2,3-dihydroxybenzoate-promoted iron uptake. Arch. Microbiol. 114:231-239.
7. Hantke, K. 1981. Regulation of ferric iron transport in Escherichia coli K-12. Isolation of a constitutive mutant. Mol. Gen. Genet. 182:288-292.
8. Hantke, K. 1983. Identification of an iron uptake system specific for coprogen and rhodotorulic acid in Escherichia coli K-12. Mol. Gen. Genet. 191: 301-306.
9. Hazumi, N., K. Matsuda, M. Sanada, N. Ohtake, and N. Tanaka. 1992. Resistance to a new catecholic cephem. BO-1341, in Pseudomonas aeruginosa PAO. J. Antimicrob. Chemother. 29:287-297.
10. Jones, R. N., E. N. Kehrberg, M. E. Erwin, S. C. Anderson, and the Fluoroquinolone Resistance Surveillance Group. 1994. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Diagn. Microbiol. Infect. Dis. 19:203-215.
11. Katsu, K., K. Kitoh, M. Inoue, and S. Mitsuhashi. 1982. In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin. Antimicrob. Agents Chemother. 22:181-185.
12. Maningo, E., and C. Watanakunakorn. 1995. Xanthomanas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J. Infect. Dis. 31:89-92.
13. Mochida, K., C. Shiraki, M. Yamasaki, T. Hirata, K. Sato, and R. Okachi. 1987. Aminothiazolylglycyl derivatives of carbacephems. J. Antibiotics 40: 14-21.
14. Mochizuki, H., Y. Oikawa, H. Yamada, S. Kusakabe, T. Shihara, K. Murakami, K. Kato, J. Ishiguro, and H. Kosuzume. 1988. Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin. J. Antibiotics 41:377-391.
15. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Nikaido, H. 1985. Role of permeability barrier in resistance to β-lactam antibiotics. Pharmacol. Ther. 27:197-231.
17. Nikaido, H. 1992. Porins and specific channels of bacterial outer membranes. Mol. Microbiol. 6:435-442.
18. Nikaido, H., and E. Y. Rosenberg. 1990. Cir and Fiu proteins in the outer membrane of Escherichia coli catalyze transport of monomeric catechols: study with β-lactam antibiotics containing catechol and analogous groups. J. Bacteriol. 172:1361-1367.
19. Postle, K. 1990. TonB and the gram-negative dilemma. Mol. Microbiol. 4:2019-2025.
20. Ross, G. W., and M. G. Boulton. 1973. Purification of β-lactamase of QAE-Sephadex. Biochim. Biophys. Acta 309:430-439.
21. Silley, P., J. W. Griffiths, D. Monsey, and A. M. Harris. 1990. Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tocB-dependent iron transport system. Antimicrob. Agents Chemother. 34:1806-1808.
22. Spratt, B. G. 1977. Properties of the penicillin-binding proteins of Escherichia coli K-12. Eur. J. Biochem. 72:341-352.
23. Sykes, R. B., D. P. Bonner, K. Bush, and N. H. Georgopapadakou. 1982. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob. Agents Chemother. 21:85-92.
24. Sykes, R. B., W. H. Koster, and D. P. Bonner. 1988. The new monobactams: chemistry and biology. J. Clin. Pharmacol. 28:113-119.
25. Wagegg, W., and V. Braun. 1981. Ferric citrate transport in Escherichia coli requires outer membrane receptor protein FecA. J. Bacteriol. 145:156-163.
26. Yoshihara, E., and T. Nakae. 1989. Identification of porins in the outer membrane of Pseudomonas aeruginosa that form small diffusion pores. J. Biol. Chem. 264:6297-6301.